Table 2.
Characteristic | Drosophila melanogaster | Galleria mellonella |
Genetic tractability | + | − |
Sequenced genome | Completed | − |
Insect mutant strain availability | + | − |
Gene microarrays | + | + |
RNA interference libraries | + | − |
Availability of phagocytic cell lines | + | + |
Potential for harvesting of phagocytes for ex vivo studies | − | + |
Adaptive immunity | − | − |
Chemokine/cytokine production | − | − |
Need for simple laboratory resources | ± | + |
Precision in fungal inoculum delivery with injection | ± | + |
Need for genetic crossing | + | − |
Overall cost | Low | Low |
Correlation of virulence factors with mammalian models | + | + |
Potential for large-scale screening studies of fungal genomes | + | + |
Survival at mammalian physiologic temperature (37°C) | - | + |
Suitable for orally absorbed antifungal compound testing studies | + | + |
Suitable for parenteral antifungal compound testing studies | ± | + |
Precision in parenteral delivery of drugs | − | + |
Potential for pharmacokinetic studies | − | − |
Potential for pharmacodynamic studies | − | + |
+ denotes the presence and − denotes the absence of the corresponding characteristic.